GP Capital Wins Honors including "Zero2IPO China Venture Capital & Private Equity Annual Ranking 2019"
- Recent reports
-
2023-04-28
Strengthening the Fulfillment of Responsibilities, Eliminating Potential Hazards: SIG Conducts Safety Inspection before "May Day" Holiday
Learn more
-
2023-04-27
Nearly 100 Invested Enterprises of SSC Selected into Global Unicorn Index 2023
Learn more
-
2023-04-26
Seizing Opportunity, Recording Lowest Coupon Rate, Enhancing Market Visibility: SSAM Successfully Issues First-Tranche MTNs in 2023
Learn more
On December 6, 2019, the list of "Zero2IPO China Venture Capital & Private Equity Annual Ranking 2019" was unveiled. GP Capital Co., Ltd. (GP Capital), a subsidiary of Shanghai International Group (SIG), was ranked 22nd among "China's Top 50 PE Institutions" and "China's Top 50 State-owned Capital Investment Institutions" by outstanding investment performance. Montage Technology funded by GP Lin'gang Intelligent Fund Investment, a subsidiary of GP Capital was listed among "2019 Most Influential VC/PE-supported IPO Cases in China".
Since 2001, Zero2IPO Research Center has continuously released 18 editions of Zero2IPO China Venture Capital & Private Equity Annual Ranking. After making analyses and selections from multiple perspectives such as the volume of managed capital available for investment in China, financing amount, the number of investment cases and comprehensive return level, the center eventually worked out tens of rankings in the categories of VC/PE, Industries, Outstanding Cases and Intermediaries in 2019, to comprehensively reflect the real market conditions and competition pattern.
2019 saw tough tests for the VC/PE market and the transformation of the market structure. On the one hand, the market remained gripped by the "difficulty in capital raising"; on the other hand, the launch of the STAR Market (Sci-tech Innovation Board) was a turnaround for the exit of numerous institutions. In this context, GP Capital has stuck to nature and origin, stayed true to its goal, kept improving its investment capacity, focused on broad health, new consumption, new materials, intelligent manufacturing, intelligent manufacturing and other fields, served the real economy, supported emerging industries and contributed to the innovative development of the real economy.